Current views in HTLV-I-associated adult T-cell leukemia/lymphoma

被引:64
作者
Nicot, C [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA
关键词
D O I
10.1002/ajh.20307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epidemiological studies have demonstrated that the relative percentage of malignant lymphoid proliferations varies widely according to geographical location and ethnic populations. HTLV-1 is the etiological agent of adult T-cell leukemia/lymphoma (ATLL) and is also associated with cutaneous T-cell lymphoma (CTCL). However, a definite role of HTLV-1 in mycosis fungoides (MF) and/or Sezary syndrome (SS) remains controversial. While most HTLV-1-infected individuals remain asymptomatic carriers, 1-5% will develop ATLL, an invariably fatal expansion of virus-infected CD4(+) T cells. This low incidence and the long latency period preceding occurrence of the disease suggest that additional factors are involved in development of ATLL. In this review, diagnosis, clinical features, and molecular pathogenesis of HTLV-1 are discussed. (C) 2005 Wiley-Liss,inc.
引用
收藏
页码:232 / 239
页数:8
相关论文
共 130 条
[1]   Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies) [J].
Agapé, P ;
Copin, MC ;
Cavrois, M ;
Panelatti, G ;
Plumelle, Y ;
Ossondo-Landeau, M ;
Quist, D ;
Grossat, N ;
Gosselin, B ;
Fenaux, P ;
Wattel, E .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (04) :394-402
[2]   COHERENT VIEW OF NON-HODGKINS-LYMPHOMA [J].
AISENBERG, AC .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2656-2675
[3]   Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis [J].
Albrecht, B ;
Lairmore, MD .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2002, 66 (03) :396-+
[4]   Human T-cell leukemia virus type 1 Tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF [J].
Arai, M ;
Ohashi, T ;
Tsukahara, T ;
Murakami, T ;
Hori, T ;
Uchiyama, T ;
Yamamoto, N ;
Kannagi, M ;
Fujii, M .
VIROLOGY, 1998, 241 (02) :298-303
[5]   Human T-lymphotropic virus type 1 (HTLV-1): Persistence and immune control [J].
Bangham, CRM .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (04) :297-303
[6]   Adult T-cell leukemia/lymphoma in northeastern Brazil:: A clinical, histopathologic, and molecular study [J].
Barbosa, HS ;
Bittencourt, AL ;
de Araújo, IB ;
Pereira, CS ;
Furlan, R ;
Pedrosa, C ;
Lessa, G ;
Harrington, W ;
Castro, BG .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (01) :65-71
[7]   Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration [J].
Barmak, K ;
Harhaj, E ;
Grant, C ;
Alefantis, T ;
Wigdahl, B .
VIROLOGY, 2003, 308 (01) :1-12
[8]   Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study [J].
Bazarbachi, A ;
Soriano, V ;
Pawson, R ;
Vallejo, A ;
Moudgil, T ;
Matutes, E ;
Peries, J ;
Molina, A ;
deThe, H ;
Schulz, TF ;
Catovsky, D ;
Gill, PS .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) :927-933
[9]   Arsenic trioxide and interferon-α synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells [J].
Bazarbachi, A ;
El-Sabban, ME ;
Nasr, R ;
Quignon, F ;
Awaraji, C ;
Kersual, J ;
Dianoux, L ;
Zermati, Y ;
Haidar, JH ;
Hermine, O ;
de Thé, H .
BLOOD, 1999, 93 (01) :278-283
[10]   Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients [J].
Bazarbachi, A ;
Hermine, O .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 :S186-S190